StockNews.com Begins Coverage on Vanda Pharmaceuticals (NASDAQ:VNDA)
StockNews.com started coverage on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a report issued on Tuesday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, Cantor Fitzgerald upped their target price on shares of Vanda Pharmaceuticals from $11.00 to $13.00 and gave the company an overweight rating in a […]
More Stories
MarketAxess (NASDAQ:MKTX) Price Target Raised to $265.00
MarketAxess (NASDAQ:MKTX – Free Report) had its price objective upped by Piper Sandler from $235.00 to $265.00 in a research...
Artis Real Estate Investment Trust Unit (TSE:AX.UN) Reaches New 12-Month High – What’s Next?
Shares of Artis Real Estate Investment Trust Unit (TSE:AX.UN – Get Free Report) hit a new 52-week high during mid-day...
Varonis Systems (NASDAQ:VRNS) Sets New 12-Month High – Here’s Why
Shares of Varonis Systems, Inc. (NASDAQ:VRNS – Get Free Report) hit a new 52-week high during mid-day trading on Wednesday...
Steelcase (NYSE:SCS) Shares Gap Up – Should You Buy?
Steelcase Inc. (NYSE:SCS – Get Free Report)’s stock price gapped up before the market opened on Wednesday . The stock...
Short Interest in DKSH Holding AG (OTCMKTS:DKSHF) Drops By 62.5%
DKSH Holding AG (OTCMKTS:DKSHF – Get Free Report) was the recipient of a significant drop in short interest in September....
Short Interest in Calavo Growers, Inc. (NASDAQ:CVGW) Drops By 62.3%
Calavo Growers, Inc. (NASDAQ:CVGW – Get Free Report) was the target of a significant decrease in short interest in September....